The below clickable headlines link directly to outside media outlets, which featured UNC School of Medicine faculty starting Friday, May 8, 2025.
UNC Researchers Uncover Molecular Mechanism Behind Hydralazine-Induced ANCA Vasculitis – Dr. Meghan Free (Newswise)
Patient Selection Is Crucial for Later-Line Treatment Decisions in Metastatic Melanoma – Dr. Stergios Moschos (OncLive)
NC hospitals in state of standby, preparing as measles threat grows – Dr. David Wohl (WRAL-TV)
6 fruits with more vitamin C than an orange – Shelly Wegman (NBC)
Eupraxia Pharmaceuticals Announces Sustained Positive Treatment Outcomes in Patients with Eosinophilic Esophagitis (EoE) After Nine Months of Receiving EP-104GI – Dr. Evan S. Dellon (Small Business Online Network)
Even simple exercises like stretching could slash Alzheimer’s risk and boost brain health, studies show – Dr. Patrick J. Smith (Natural News)
“Health policy expert highlights the importance of state-level urology advocacy.” – Dr. Hans Arora (Urology Times)
“Advancing Diagnostic Excellence in Prostate Cancer: Insights From the Quality Summit on Prostate MRI.” Dr. Zachary Feuer, Dr. Hung-Jui (Ray) Tan, Dr. Mathew Nielsen (AUA News)
Bevacizumab Addition May Be Beneficial for Melanoma Brain Metastases, Study Suggests – Dr. Stergios Moschos (oncologynewscentral.com)
Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease – Dr. Evan S. Dellon (USA Life Sciences Database)
Hepatitis A Outbreak in Los Angeles: Everything We Know – Dr. Stanley Lemon (Newsweek)
Your baby’s PURPLE crying is difficult but normal – Dr. Adam Zolotor (WRAL-TV)
Understanding treatment options for rosacea – Dr. Margaret Coates (WRAL-TV)
Early Studies Suggest GLP-1s May Improve COPD Symptoms – Dr. M. Bradley Drummond (MSN.com)
Early Studies Suggest GLP-1s May Improve COPD Symptoms – Dr. M. Bradley Drummond (Verywell Health)
Eupraxia Pharmaceuticals to Host Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE) on May 9, 2025 – Dr. Evan Dellon (GlobeNewswire)
Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update – Dr. James (Chip) F. Howard (Scitech News Network)